{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T14:41:01Z","timestamp":1689432061704},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s00432-022-04349-8","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T02:04:41Z","timestamp":1663553081000},"page":"4443-4453","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical implications and genetical insights of SOX6 expression in acute myeloid leukemia"],"prefix":"10.1007","volume":"149","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duanfeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haigang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"issue":"1","key":"4349_CR1","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1038\/s41598-019-39926-4","volume":"9","author":"G Barbarani","year":"2019","unstructured":"Barbarani G, Fugazza C, Barabino SML, Ronchi AE (2019) SOX6 blocks the proliferation of BCR-ABL1(+) and JAK2V617F(+) leukemic cells. Sci Rep 9(1):3388. https:\/\/doi.org\/10.1038\/s41598-019-39926-4","journal-title":"Sci Rep"},{"issue":"13","key":"4349_CR2","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1182\/blood-2010-04-282350","volume":"117","author":"C Cantu","year":"2011","unstructured":"Cantu C, Ierardi R, Alborelli I, Fugazza C, Cassinelli L, Piconese S, Ronchi A (2011) Sox6 enhances erythroid differentiation in human erythroid progenitors. Blood 117(13):3669\u20133679. https:\/\/doi.org\/10.1182\/blood-2010-04-282350","journal-title":"Blood"},{"issue":"9","key":"4349_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1517\/14728222.2012.709239","volume":"16","author":"SD Castillo","year":"2012","unstructured":"Castillo SD, Sanchez-Cespedes M (2012) The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin Ther Targets 16(9):903\u2013919. https:\/\/doi.org\/10.1517\/14728222.2012.709239","journal-title":"Expert Opin Ther Targets"},{"issue":"10","key":"4349_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/mc.23246","volume":"59","author":"L Chen","year":"2020","unstructured":"Chen L, Xie Y, Ma X, Zhang Y, Li X, Zhang F, Fu B (2020) SOX6 represses tumor growth of clear cell renal cell carcinoma by HMG domain-dependent regulation of Wnt\/beta-catenin signaling. Mol Carcinog 59(10):1159\u20131173. https:\/\/doi.org\/10.1002\/mc.23246","journal-title":"Mol Carcinog"},{"issue":"12","key":"4349_CR5","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H Dohner","year":"2015","unstructured":"Dohner H, Weisdorf DJ, Bloomfield CD (2015) Acute myeloid leukemia. N Engl J Med 373(12):1136\u20131152. https:\/\/doi.org\/10.1056\/NEJMra1406184","journal-title":"N Engl J Med"},{"issue":"4","key":"4349_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, Bloomfield CD (2017) Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 129(4):424\u2013447. https:\/\/doi.org\/10.1182\/blood-2016-08-733196","journal-title":"Blood"},{"issue":"2\u20134","key":"4349_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1159\/000078217","volume":"105","author":"C Dong","year":"2004","unstructured":"Dong C, Wilhelm D, Koopman P (2004) Sox genes and cancer. Cytogenet Genome Res 105(2\u20134):442\u2013447. https:\/\/doi.org\/10.1159\/000078217","journal-title":"Cytogenet Genome Res"},{"issue":"4","key":"4349_CR8","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1182\/blood-2006-02-004184","volume":"108","author":"B Dumitriu","year":"2006","unstructured":"Dumitriu B, Patrick MR, Petschek JP, Cherukuri S, Klingmuller U, Fox PL, Lefebvre V (2006) Sox6 cell-autonomously stimulates erythroid cell survival, proliferation, and terminal maturation and is thereby an important enhancer of definitive erythropoiesis during mouse development. Blood 108(4):1198\u20131207. https:\/\/doi.org\/10.1182\/blood-2006-02-004184","journal-title":"Blood"},{"issue":"8","key":"4349_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012088","volume":"5","author":"B Dumitriu","year":"2010","unstructured":"Dumitriu B, Bhattaram P, Dy P, Huang Y, Quayum N, Jensen J, Lefebvre V (2010) Sox6 is necessary for efficient erythropoiesis in adult mice under physiological and anemia-induced stress conditions. PLoS ONE 5(8):e12088. https:\/\/doi.org\/10.1371\/journal.pone.0012088","journal-title":"PLoS ONE"},{"issue":"Pt 1","key":"4349_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","volume":"67","author":"D Grimm","year":"2020","unstructured":"Grimm D, Bauer J, Wise P, Kruger M, Simonsen U, Wehland M, Corydon TJ (2020) The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol 67(Pt 1):122\u2013153. https:\/\/doi.org\/10.1016\/j.semcancer.2019.03.004","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"4349_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.canep.2013.05.002","volume":"37","author":"X Guo","year":"2013","unstructured":"Guo X, Yang M, Gu H, Zhao J, Zou L (2013) Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma. Cancer Epidemiol 37(5):732\u2013736. https:\/\/doi.org\/10.1016\/j.canep.2013.05.002","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"4349_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"M Huang","year":"1988","unstructured":"Huang M, Ye Y, Chen S, Chai J, Lu J, Zhoa L, Wang Z (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72(2):567\u2013572","journal-title":"Blood"},{"issue":"24","key":"4349_CR13","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1182\/bloodadvances.2020002673","volume":"4","author":"N Jahn","year":"2020","unstructured":"Jahn N, Terzer T, Strang E, Dolnik A, Cocciardi S, Panina E, Dohner K (2020) Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implication. Blood Adv 4(24):6342\u20136352. https:\/\/doi.org\/10.1182\/bloodadvances.2020002673","journal-title":"Blood Adv"},{"issue":"10","key":"4349_CR14","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00277-020-04235-8","volume":"99","author":"M Jentzsch","year":"2020","unstructured":"Jentzsch M, Bill M, Grimm J, Brauer D, Backhaus D, Goldmann K, Schwind S (2020) Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML. Ann Hematol 99(10):2417\u20132427. https:\/\/doi.org\/10.1007\/s00277-020-04235-8","journal-title":"Ann Hematol"},{"issue":"3","key":"4349_CR15","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1111\/jcmm.13470","volume":"22","author":"W Jiang","year":"2018","unstructured":"Jiang W, Yuan Q, Jiang Y, Huang L, Chen C, Hu G, Yang L (2018) Identification of Sox6 as a regulator of pancreatic cancer development. J Cell Mol Med 22(3):1864\u20131872. https:\/\/doi.org\/10.1111\/jcmm.13470","journal-title":"J Cell Mol Med"},{"issue":"1","key":"4349_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12967-021-02873-8","volume":"19","author":"D Jiang","year":"2021","unstructured":"Jiang D, He Y, Mo Q, Liu E, Li X, Huang L, Shao H (2021) PRICKLE1, a Wnt\/PCP signaling component, is overexpressed and associated with inferior prognosis in acute myeloid leukemia. J Transl Med 19(1):211. https:\/\/doi.org\/10.1186\/s12967-021-02873-8","journal-title":"J Transl Med"},{"issue":"19","key":"4349_CR17","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1200\/JCO.2008.20.6110","volume":"27","author":"C Langer","year":"2009","unstructured":"Langer C, Marcucci G, Holland KB, Radmacher MD, Maharry K, Paschka P, Bloomfield CD (2009) Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 27(19):3198\u20133204. https:\/\/doi.org\/10.1200\/JCO.2008.20.6110","journal-title":"J Clin Oncol"},{"issue":"5","key":"4349_CR18","doi-asserted-by":"publisher","first-page":"101042831770550","DOI":"10.1177\/1010428317705508","volume":"39","author":"Y Li","year":"2017","unstructured":"Li Y, Xiao M, Guo F (2017) The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis. Tumour Biol 39(5):1010428317705508. https:\/\/doi.org\/10.1177\/1010428317705508","journal-title":"Tumour Biol"},{"key":"4349_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.740642","volume":"11","author":"C Liang","year":"2021","unstructured":"Liang C, Zhao Y, Chen C, Huang S, Deng T, Zeng X, Li Y (2021) Higher TOX genes expression is associated with poor overall survival for patients with acute myeloid leukemia. Front Oncol 11:740642. https:\/\/doi.org\/10.3389\/fonc.2021.740642","journal-title":"Front Oncol"},{"key":"4349_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14051165","author":"X Luo","year":"2022","unstructured":"Luo X, Ji X, Xie M, Zhang T, Wang Y, Sun M, Xia L (2022) Advance of SOX transcription factors in hepatocellular carcinoma: from role tumor immune relevance to targeted therapy. Cancers (basel). https:\/\/doi.org\/10.3390\/cancers14051165","journal-title":"Cancers (basel)"},{"issue":"1","key":"4349_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/2211-5463.12762","volume":"10","author":"L Lv","year":"2020","unstructured":"Lv L, Zhou M, Zhang J, Liu F, Qi L, Zhang S, Yu Y (2020) SOX6 suppresses the development of lung adenocarcinoma by regulating expression of p53, p21(CIPI), cyclin D1 and beta-catenin. FEBS Open Bio 10(1):135\u2013146. https:\/\/doi.org\/10.1002\/2211-5463.12762","journal-title":"FEBS Open Bio"},{"issue":"5","key":"4349_CR22","doi-asserted-by":"publisher","first-page":"1783081","DOI":"10.1080\/23723556.2020.1783081","volume":"7","author":"A Marchetto","year":"2020","unstructured":"Marchetto A, Grunewald TGP (2020) SOX6: a double-edged sword for Ewing sarcoma. Mol Cell Oncol 7(5):1783081. https:\/\/doi.org\/10.1080\/23723556.2020.1783081","journal-title":"Mol Cell Oncol"},{"issue":"1","key":"4349_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2016.08.005","volume":"31","author":"J Prada-Arismendy","year":"2017","unstructured":"Prada-Arismendy J, Arroyave JC, Rothlisberger S (2017) Molecular biomarkers in acute myeloid leukemia. Blood Rev 31(1):63\u201376. https:\/\/doi.org\/10.1016\/j.blre.2016.08.005","journal-title":"Blood Rev"},{"issue":"1","key":"4349_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1158\/1078-0432.CCR-10-1155","volume":"17","author":"YR Qin","year":"2011","unstructured":"Qin YR, Tang H, Xie F, Liu H, Zhu Y, Ai J, Guan XY (2011) Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma. Clin Cancer Res 17(1):46\u201355. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1155","journal-title":"Clin Cancer Res"},{"issue":"8","key":"4349_CR25","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/sj.leu.2402175","volume":"15","author":"H Quentmeier","year":"2001","unstructured":"Quentmeier H, Drexler HG, Fleckenstein D, Zaborski M, Armstrong A, Sims JE, Lyman SD (2001) Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation. Leukemia 15(8):1286\u20131292. https:\/\/doi.org\/10.1038\/sj.leu.2402175","journal-title":"Leukemia"},{"issue":"25","key":"4349_CR26","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1182\/blood-2010-06-290536","volume":"116","author":"S Schwind","year":"2010","unstructured":"Schwind S, Marcucci G, Maharry K, Radmacher MD, Mrozek K, Holland KB, Bloomfield CD (2010) BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood 116(25):5660\u20135669. https:\/\/doi.org\/10.1182\/blood-2010-06-290536","journal-title":"Blood"},{"issue":"10147","key":"4349_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/s0140-6736(18)31041-9","volume":"392","author":"NJ Short","year":"2018","unstructured":"Short NJ, Rytting ME, Cortes JE (2018) Acute myeloid leukaemia. The Lancet 392(10147):593\u2013606. https:\/\/doi.org\/10.1016\/s0140-6736(18)31041-9","journal-title":"The Lancet"},{"issue":"2","key":"4349_CR28","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.yexcr.2018.02.036","volume":"365","author":"WL Tian","year":"2018","unstructured":"Tian WL, Guo R, Wang F, Jiang ZX, Tang P, Huang YM, Sun L (2018) The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia. Exp Cell Res 365(2):185\u2013193. https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.036","journal-title":"Exp Cell Res"},{"key":"4349_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.leukres.2018.02.001","volume":"67","author":"N Tosic","year":"2018","unstructured":"Tosic N, Petrovic I, Grujicic NK, Davidovic S, Virijevic M, Vukovic NS, Stevanovic M (2018) Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia. Leuk Res 67:32\u201338. https:\/\/doi.org\/10.1016\/j.leukres.2018.02.001","journal-title":"Leuk Res"},{"issue":"1","key":"4349_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF02482175","volume":"21","author":"R Ueda","year":"2004","unstructured":"Ueda R, Yoshida K, Kawakami Y, Kawase T, Toda M (2004) Expression of a transcriptional factor, SOX6, in human gliomas. Brain Tumor Pathol 21(1):35\u201338. https:\/\/doi.org\/10.1007\/BF02482175","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"4349_CR31","doi-asserted-by":"publisher","first-page":"6803","DOI":"10.3892\/mmr.2018.8681","volume":"17","author":"Z Wang","year":"2018","unstructured":"Wang Z, Li J, Li K, Xu J (2018) SOX6 is downregulated in osteosarcoma and suppresses the migration, invasion and epithelial-mesenchymal transition via TWIST1 regulation. Mol Med Rep 17(5):6803\u20136811. https:\/\/doi.org\/10.3892\/mmr.2018.8681","journal-title":"Mol Med Rep"},{"issue":"1","key":"4349_CR32","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1038\/s41598-018-38408-3","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang Y, Richter L, Becker M, Amador C, Hyde RK (2019) IL1RL1 is dynamically expressed on Cbfb-MYH11(+) leukemia stem cells and promotes cell survival. Sci Rep 9(1):1729. https:\/\/doi.org\/10.1038\/s41598-018-38408-3","journal-title":"Sci Rep"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04349-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04349-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T14:06:34Z","timestamp":1689429994000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04349-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04349-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"4 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of The Third Xiangya Hospital of the Central South University. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants in the study provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}